[Federal Register Volume 79, Number 94 (Thursday, May 15, 2014)]
[Notices]
[Page 27936]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-11112]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: SIEMENS 
Healthcare Diagnostics, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before July 14, 2014.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, and dispensers of controlled substances 
(other than final orders in connection with suspension, denial, or 
revocation of registration) has been re-delegated to the Deputy 
Assistant Administrator of the DEA Office of Diversion Control 
(``Deputy Assistant Administrator'') pursuant to sec. 7(g) of 28 CFR 
part 0, subpart R, App.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
November 26, 2013, Siemens Healthcare Diagnostics, Inc., Attn: RA, 100 
GBC Drive, Mail Stop 514, Newark, Delaware 19702, applied to be 
registered as a bulk manufacturer of the following basic classes of 
narcotic or non-narcotic controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Ecgonine (9180)............................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substances in 
bulk to be used in the manufacture of reagents and drug calibrator 
controls which are DEA exempt products.
    In reference to drug code 7370 the company plans to bulk 
manufacture a synthetic tetrahydrocannabinol. No other activity for 
this drug code is authorized for this registration.

    Dated: May 2, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-11112 Filed 5-14-14; 8:45 am]
BILLING CODE 4410-09-P